Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir F 18 PET Imaging vs Autopsy in Alzheimer's Pathology
NCT00857415Phase 3Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Dec 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Florbetapir in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
Florbetapir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00857415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857415.